Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 27:11:1327746.
doi: 10.3389/fmed.2024.1327746. eCollection 2024.

COVID-19 mortality rate and its determinants in Ethiopia: a systematic review and meta-analysis

Temesgen Gebeyehu Wondmeneh  1 , Jemal Abdu Mohammed  1
Affiliations

COVID-19 mortality rate and its determinants in Ethiopia: a systematic review and meta-analysis

Temesgen Gebeyehu Wondmeneh et al. Front Med (Lausanne). .

Abstract

Background: The COVID-19 mortality rate continues to be high in low-income countries like Ethiopia as the new variant's transmission expands and the countries' limited capacity to combat the disease causes severe outcomes, including deaths. The aim of this study is to determine the magnitude of the COVID-19 mortality rate and its determinants in Ethiopia.

Methods: The main electronic databases searched were PubMed, CINAHL, Google Scholar, and African journals online. The included studies' qualities were assessed independently using the Newcastle-Ottawa scale. The data was extracted in Microsoft Excel spreadsheet format. The pooled effect size and odds ratios with 95% confidence intervals across studies were determined using the random-effects model. I2 is used to estimate the percentage of overall variation across studies due to heterogeneity. Egger's test and funnel plot were used to find the published bias. A subgroup analysis was conducted. The effect of a single study on the overall estimation was determined by sensitivity analysis.

Results: A total of 21 studies with 42,307 study participants were included in the final analysis. The pooled prevalence of COVID-19 mortality was 14.44% (95% CI: 10.35-19.08%), with high significant heterogeneity (I2 = 98.92%, p < 0.001). The risk of mortality from COVID-19 disease was higher for patients with comorbidity (AHR = 1.84, 95% CI: 1.13-2.54) and cardiovascular disease (AHR = 2, 95% CI: 1.09-2.99) than their counterparts without these conditions.

Conclusion: A significant number of COVID-19 patients died in Ethiopia. COVID-19 patients with comorbidities, particularly those with cardiovascular disease, should receive special attention to reduce COVID-19 mortality.

Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/, registration identifier (ID) CRD42020165740.

Keywords: COVID-19; Ethiopia; mortality; rate; risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow chart for the selection of studies for systematic review.
Figure 2
Figure 2
The pooled prevalence of COVlD-19 mortality.
Figure 3
Figure 3
The pooled incidence rate of COVID-19 mortality per 1000 persons per day.
Figure 4
Figure 4
Funnel plot for publication bias for the pooled prevalence of COVID-19 morality.
Figure 5
Figure 5
Sensitivity analysis for pooled prevalence of COVID-19 morality.
Figure 6
Figure 6
The association between COVID-19 morality and comorbidity.
Figure 7
Figure 7
The association between COVID-19 morality and hypertension.
Figure 8
Figure 8
The association between COVID-19 morality and cardiovascular disease.
Figure 9
Figure 9
The association between COVID-19 morality and kidney disease.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Oommen A. Epidemiology of COVID-19. J Dig Endosc. (2020) 11:03–7. doi: 10.1055/s-0040-1712187 - DOI
    1. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Statpearls. (2022). - PubMed
    1. Sousa G, Garces T, Cestari V, Florêncio R, Moreira T, Pereira M. Mortality and survival of COVID-19. Epidemiol Infect. (2020) 148:148. doi: 10.1017/S0950268820001405 - DOI - PMC - PubMed
    1. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. (2020) 20:773. doi: 10.1016/S1473-3099(20)30195-X, PMID: - DOI - PMC - PubMed
    1. WHO . COVID-19 response in Africa bulletin: Situation and response in the WHO AFRO region. (Issue 10, Dec-Feb 2023). Available at: https://reliefweb.int/report/world/covid-19-response-africa-bulletin-sit... (Accessed May 12, 2023).

Publication types

LinkOut - more resources